Targeting malignant B cells with an immunotoxin against ROR1

The selective cell surface expression of receptor tyrosine kinase-like orphan receptor 1 (ROR1) in chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) has made ROR1 a novel and promising target for therapeutic monoclonal antibodies (mAbs). Four mouse mAbs generated by hybridoma technol...

Descripción completa

Detalles Bibliográficos
Autores principales: Baskar, Sivasubramanian, Wiestner, Adrian, Wilson, Wyndham H., Pastan, Ira, Rader, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355487/
https://www.ncbi.nlm.nih.gov/pubmed/22531447
http://dx.doi.org/10.4161/mabs.19870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355487/
https://www.ncbi.nlm.nih.gov/pubmed/22531447
http://dx.doi.org/10.4161/mabs.19870

Ejemplares similares